Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

Form 8 (OPD) - finnCap Group plc

1 Nov 2022 11:02

RNS Number : 9145E
Panmure Gordon Group Limited
01 November 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Panmure Gordon Group Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

finnCap Group plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

31 October 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

Panmure Gordon Group Limited

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 1p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

Nil

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

None

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

1 November 2022

Contact name:

Barry Wainwright

Telephone number:

020 7886 2500

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEBKDBKDBDDKDK
Date   Source Headline
1st Jun 20217:00 amRNSBlock Admission Return and Total Voting Rights
13th May 20217:00 amRNSDirector Dealing, Option Exercise & TVR
30th Apr 20217:00 amRNSTotal Voting Rights
8th Apr 202111:06 amRNSSecond Price Monitoring Extn
8th Apr 202111:00 amRNSPrice Monitoring Extension
7th Apr 20217:00 amRNSFY21 Unaudited Total Income - Strong end to FY21
1st Apr 20217:00 amRNSTotal Voting Rights
5th Mar 20219:16 amRNSDirectors’ Dealings
3rd Mar 20214:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:35 pmRNSPrice Monitoring Extension
3rd Mar 20211:55 pmRNSFY21 Trading Update
1st Mar 20217:00 amRNSTotal Voting Rights
23rd Feb 20217:00 amRNSAppointment of Broker
1st Feb 20217:00 amRNSTotal Voting Rights
4th Jan 20217:00 amRNSTotal Voting Rights
4th Dec 20207:00 amRNSDirector/PDMR Shareholding
1st Dec 20207:00 amRNSBlock Admission Return and Total Voting Rights
18th Nov 202010:54 amRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSBoard Changes
18th Nov 20207:00 amRNSInterim Results and Interim Dividend
30th Oct 20207:00 amRNSTotal Voting Rights
1st Oct 20207:00 amRNSTotal Voting Rights
21st Sep 20202:12 pmRNSResult of AGM
21st Sep 20207:00 amRNSAGM Trading Statement
3rd Sep 20209:12 amRNSOption Exercise - Director/PDMR Shareholding
1st Sep 202011:40 amRNSTotal Voting Rights- Replacement
1st Sep 20207:00 amRNSTotal Voting Rights
17th Aug 20207:00 amRNSAdditional Block Admission of Shares
13th Aug 202012:30 pmRNSOption Grant
31st Jul 202010:18 amRNSAnnual Report and Annual General Meeting Notice
31st Jul 20207:00 amRNSTotal Voting Rights
7th Jul 20207:00 amRNSPreliminary results - year ended 31 March 2020
1st Jul 20207:00 amRNSTotal Voting Rights
16th Jun 20208:56 amRNSChange of Registered Office
1st Jun 20207:00 amRNSBlock Admission Return and Total Voting Rights
26th May 202010:20 amRNSDirector/PDMR Shareholding
26th May 20207:00 amRNSProperty Financing
20th May 20207:00 amRNSDirectorate Changes
6th May 20209:54 amRNSDirector’s Dealing and Concert Party Update
1st May 20207:00 amRNSTotal Voting Rights
2nd Apr 20207:00 amRNSOption Surrenders and Grants
1st Apr 20203:11 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSTrading Update
12th Mar 20201:44 pmRNSHolding(s) in Company
4th Mar 20207:00 amRNSTotal Voting Rights
27th Feb 20207:00 amRNSTrading Update
14th Feb 20207:00 amRNSNew Director Appointment
4th Feb 20207:00 amRNSTotal Voting Rights
23rd Jan 20203:32 pmRNSDirector/PDMR Shareholding
17th Jan 20202:52 pmRNSSigning of new lease to consolidate premises

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.